Israel Englander’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$22.5M Sell
56,600
-194,000
-77% -$55.2M 0.01% 1525
2026
Q1
$43.5M Buy
250,600
+165,400
+194% +$33.9M 0.02% 927
2025
Q4
$21.8M Sell
85,200
-395,500
-82% -$104M 0.01% 1502
2025
Q3
$125M Buy
480,700
+417,900
+665% +$110M 0.05% 336
2025
Q2
$15.4M Sell
62,800
-8,700
-12% -$2.17M 0.01% 1832
2025
Q1
$18.9M Sell
71,500
-200
-0.3% -$54.1K 0.01% 1574
2024
Q4
$18.2M Sell
71,700
-86,100
-55% -$23.1M 0.01% 1605
2024
Q3
$50M Buy
157,800
+133,800
+558% +$47.6M 0.02% 809
2024
Q2
$8.97M Sell
24,000
-214,200
-90% -$72.3M ﹤0.01% 2184
2024
Q1
$82.6M Buy
238,200
+132,700
+126% +$50.3M 0.04% 558
2023
Q4
$48.3M Buy
105,500
+71,100
+207% +$35M 0.02% 819
2023
Q3
$16.7M Sell
34,400
-13,700
-28% -$6.44M 0.01% 1580
2023
Q2
$21.5M Sell
48,100
-34,500
-42% -$17.4M 0.01% 1325
2023
Q1
$40.1M Sell
82,600
-6,700
-8% -$3.31M 0.02% 837
2022
Q4
$45.7M Buy
89,300
+35,700
+67% +$18.8M 0.03% 806
2022
Q3
$26M Sell
53,600
-9,600
-15% -$4.67M 0.02% 1103
2022
Q2
$29.6M Buy
63,200
+20,900
+49% +$9.3M 0.02% 969
2022
Q1
$18.4M Buy
42,300
+5,800
+16% +$2.43M 0.01% 1475
2021
Q4
$16.9M Sell
36,500
-11,800
-24% -$5.22M 0.01% 1601
2021
Q3
$18.8M Buy
48,300
+11,800
+32% +$5.01M 0.01% 1392
2021
Q2
$16.2M Sell
36,500
-800
-2% -$350K 0.01% 1404
2021
Q1
$15.6M Sell
37,300
-7,800
-17% -$3.11M 0.01% 1318
2020
Q4
$18.5M Buy
45,100
+21,500
+91% +$8.94M 0.01% 1133
2020
Q3
$9.77K Sell
23,600
-22,400
-49% -$9.01M 0.01% 1273
2020
Q2
$17.8M Buy
+46,000
New +$17.2M 0.02% 809
2019
Q2
Sell
-40,200
Closed -$10.7M 4215
2019
Q1
$10.7M Buy
+40,200
New +$11.6M 0.02% 1197
2015
Q3
Sell
-30,000
Closed -$5.74M 3574
2015
Q2
$5.74M Buy
+30,000
New +$5.57M 0.01% 1311
2014
Q1
Sell
-4,000
Closed -$413K 3655
2013
Q4
$413K Buy
+4,000
New +$392K ﹤0.01% 2844
2013
Q3
Sell
-150,000
Closed -$12.7M 3426
2013
Q2
$12.7M Buy
+150,000
New +$11.8M 0.04% 506

Other funds holding HUM

Israel Englander's HUM Position: Q2 2026 in Review

Israel Englander increased its Humana (HUM) stake by 213% in Q2 2026, buying an estimated $68.4M and bringing the position to 352,698 shares worth $140M. The position accounts for 0.05% of the portfolio, ranked #368.

Israel Englander first reported a position in HUM in Q2 2013 and has held it in 51 quarters since. The position peaked at $413M in Q3 2023. 919 funds tracked by Wall St. Rank hold HUM as of Q2 2026.

  • Israel Englander held 352,698 shares of Humana worth $140M as of Q2 2026.
  • Israel Englander bought 240,080 Humana shares in Q2 2026, an estimated $68.4M.
  • Humana made up 0.05% of Israel Englander's portfolio in Q2 2026, its #368 holding.
  • Israel Englander first reported a position in Humana in Q2 2013 and has held it in 51 quarters since.
  • Israel Englander's Humana position peaked at $413M in Q3 2023.
  • 919 funds tracked by Wall St. Rank held Humana as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.